BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ren Y, Wang X, Liang H, He W, Zhao X. Mechanism of miR-30b-5p-Loaded PEG-PLGA Nanoparticles for Targeted Treatment of Heart Failure. Front Pharmacol 2021;12:745429. [PMID: 34658880 DOI: 10.3389/fphar.2021.745429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Bian R, Xu X, Li W. Uncovering the molecular mechanisms between heart failure and end-stage renal disease via a bioinformatics study. Front Genet 2022;13:1037520. [PMID: 36704339 DOI: 10.3389/fgene.2022.1037520] [Reference Citation Analysis]
2 de Souza Ferreira JN, Vasconcelos VVV, Figueiredo BS, Alves DP, de Abreu ALLV, de Souza PP, Costa DLN, da Silva AR. PLGA nanoparticles for treatment of cardiovascular diseases. Poly(Lactic-Co-glycolic Acid) (PLGA) Nanoparticles for Drug Delivery 2023. [DOI: 10.1016/b978-0-323-91215-0.00015-7] [Reference Citation Analysis]
3 Macedo LB, Codevilla CF, Mathes D, Maia BC, Rolim CMB, Nogueira-librelotto DR. Biofate and cellular interactions of PLGA nanoparticles. Poly(Lactic-Co-glycolic Acid) (PLGA) Nanoparticles for Drug Delivery 2023. [DOI: 10.1016/b978-0-323-91215-0.00003-0] [Reference Citation Analysis]
4 Chung C, Chung S, Cheng Y, Yang C, Chien C. Long-Lasting Exendin-4-Loaded PLGA Nanoparticles Ameliorate Cerebral Ischemia/Reperfusion Damage in Diabetic Rats. JPM 2022;12:390. [DOI: 10.3390/jpm12030390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]